Sanofi is to fund key diabetes training to care home staff to help improve health outcomes. It is thought 450,000 people currently reside in care
In an article for the New York Times, Donald McNeil reported, “With insulin prices skyrocketing and substantial shortages developing in poorer countries, the World Health
Abbott and Sanofi are partnering to integrate glucose sensing and insulin delivery technologies that would help to further simplify how people with diabetes manage their
A company developing and manufacturing advanced wearable infusion devices has entered into a multi-product development agreement with insulin supplier Sanofi. Developed and manufactured by Enable
Sanofi has launched a campaign to take action for an individualised approach to treatment for people living with diabetes, to improve their quality of life
Commenting on news stories about the possibility of medical supplies being jeopardized by the looming decision about Britain leaving the EU, JDRF has affirmed that
Sanofi has lead a round of investment for Enable Injections’ enFuse, an on-body drug-delivery system. Previous investors, including the Cleveland Clinic and CincyTech, and private
Research published at the end of 2016 by Sanofi showed that negative emotions are jeopardising the ability of people living with Type 2 diabetes (T2D)
JDRF, the type 1 diabetes charity invites you to join 60 children and adults living with type 1 diabetes as they quiz the Minister for
[issuu width=420 height=297 backgroundColor=%23222222 documentId=120327100504-c1f5cb1eedb04ec3a3ced1995e042301 name=desang_issue_21_the_colour_connection username=desangmedia tag=accu-chek unit=px id=4fc3e904-77d9-a208-3421-8699c49423ca v=2]
